"What" Series

What is Phagocytosis?

28 March 2024
2 min read

Phagocytosis is a crucial process in the immune system where certain specialized cells, known as phagocytes, engulf and ingest foreign particles, dead cells, or pathogens such as bacteria and viruses. This process is essential for the body's defense against infections and for maintaining tissue homeostasis.

Key aspects of phagocytosis include:

·Phagocytes: The primary cells involved in phagocytosis include macrophages, neutrophils, and dendritic cells. These cells are part of the innate immune system and are capable of recognizing and responding to foreign substances.

·Recognition: Phagocytes identify pathogens or debris through specific receptors on their surface that recognize molecular patterns associated with the foreign particles.

·Engulfment: Once the target is recognized, the phagocyte extends its plasma membrane around the particle, forming a phagosome, which is a vesicle containing the engulfed material.

·Digestion: The phagosome fuses with a lysosome, an organelle containing digestive enzymes and antimicrobial agents. This fusion results in the formation of a phagolysosome, where the engulfed material is broken down and destroyed.

·Elimination: The digested material is then processed and presented on the cell surface as antigens, which can stimulate the adaptive immune response, involving T cells and B cells.

·Inflammation: Phagocytosis can also trigger an inflammatory response, attracting more immune cells to the site of infection or injury to aid in the clearance of pathogens and promote tissue repair.

Phagocytosis is a vital part of the body's first line of defense and works in conjunction with other immune responses to protect the body from disease and maintain overall health.

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

Astria Therapeutics Reports Promising ALPHA-STAR Phase 1b/2 Results for HAE Using STAR-0215
Latest Hotspot
3 min read
Astria Therapeutics Reports Promising ALPHA-STAR Phase 1b/2 Results for HAE Using STAR-0215
28 March 2024
Astria Therapeutics Reveals Encouraging Early Findings in ALPHA-STAR Phase 1b/2 Study for HAE with STAR-0215.
Read →
Synapse Simplified: How to Find Carbamazepine Information
Drug Insights
2 min read
Synapse Simplified: How to Find Carbamazepine Information
28 March 2024
Carbamazepine, a minuscule molecule drug, exerts its therapeutic effect through the blocking of sodium channels in the human body.
Read →
Ultomiris Approved by US to Treat Adults with NMOSD
Latest Hotspot
3 min read
Ultomiris Approved by US to Treat Adults with NMOSD
28 March 2024
Ultomiris receives US green light to treat adult patients with spectrum disorder related to neuromyelitis optica (NMOSD).
Read →
2023 FDA-Approved GPCR-Targeted New Drugs Roundup
Drug Highlight
11 min read
2023 FDA-Approved GPCR-Targeted New Drugs Roundup
28 March 2024
This article introduces the new drugs related to GPCR that were approved by the FDA in 2023.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.